Donepezil, a piperidine derivative that inhibits acetylcholinesterase (AChE), shows cognitive improvement in AD, especially in terms of functional and behavioral outcomes, though it is associated with dose-dependent side effects such as nausea, vomiting, and muscle cramps. This evidence concerns the gene ACHE and Alzheimer disease.